KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationLeasesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)
Ratios

Arbutus Biopharma (ABUS) Depreciation Expense: 2009-2021

Historic Depreciation Expense for Arbutus Biopharma (ABUS) over the last 12 years, with Sep 2021 value amounting to $447,000.

  • Arbutus Biopharma's Depreciation Expense fell 8.78% to $447,000 in Q3 2021 from the same period last year, while for Sep 2021 it was $1.8 million, marking a year-over-year decrease of 9.26%. This contributed to the annual value of $2.0 million for FY2020, which is 2.47% down from last year.
  • Per Arbutus Biopharma's latest filing, its Depreciation Expense stood at $447,000 for Q3 2021, which was up 2.52% from $436,000 recorded in Q2 2021.
  • In the past 5 years, Arbutus Biopharma's Depreciation Expense ranged from a high of $620,000 in Q4 2017 and a low of $334,000 during Q1 2017.
  • For the 3-year period, Arbutus Biopharma's Depreciation Expense averaged around $484,727, with its median value being $500,000 (2020).
  • As far as peak fluctuations go, Arbutus Biopharma's Depreciation Expense skyrocketed by 103.78% in 2017, and later fell by 18.71% in 2018.
  • Quarterly analysis of 5 years shows Arbutus Biopharma's Depreciation Expense stood at $620,000 in 2017, then dropped by 18.71% to $504,000 in 2018, then climbed by 0.60% to $507,000 in 2019, then declined by 3.94% to $487,000 in 2020, then decreased by 8.78% to $447,000 in 2021.
  • Its Depreciation Expense stands at $447,000 for Q3 2021, versus $436,000 for Q2 2021 and $443,000 for Q1 2021.